Mark DeNichilo
Impact in
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
Papers in
-
- Angiogenesis and VEGF in Cancer 4
- Connective Tissue Growth Factor Research 4
- Bone Metabolism and Diseases 3
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 6
- Immune cells in cancer 3
- Co-authors
- Pedro Cortés (2 shared papers)Jerry Yee (2 shared papers)Bruce L. Riser (2 shared papers)Robert G. Narins (1 shared paper)Shinong Wang (1 shared paper)Raimund Hirschberg (1 shared paper)Carrie E. Brubaker (1 shared paper)Andreas Evdokiou (12 shared papers)
- Journals
- Cancer Medicine (2 papers)Kidney International (2 papers)Molecular Oncology (2 papers)International Journal of Oncology (2 papers)Cancer Letters (2 papers)
- Partner nations
- AustraliaUnited StatesGermany
In The Last Decade
Mark DeNichilo
24 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 91
- Nephrology 179
- Clinical Biochemistry 74
- Rehabilitation 62
- Molecular Biology 651
- Pathology and Forensic Medicine 133
Countries citing papers authored by Mark DeNichilo
This map shows the geographic impact of Mark DeNichilo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark DeNichilo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark DeNichilo more than expected).
Fields of papers citing papers by Mark DeNichilo
This network shows the impact of papers produced by Mark DeNichilo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark DeNichilo. The network helps show where Mark DeNichilo may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark DeNichilo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 350 | |
| 2 | 2001 | 186 | |
| 3 | 2001 | 107 | |
| 4 | 2008 | 105 | |
| 5 | 2003 | 83 | |
| 6 | 2017 | 50 | |
| 7 | 2014 | 42 | |
| 8 | 1991 | 36 | |
| 9 | 2015 | 32 | |
| 10 | 2015 | 28 | |
| 11 | 2016 | 27 | |
| 12 | 2021 | 26 | |
| 13 | 2016 | 22 | |
| 14 | 2014 | 19 | |
| 15 | 2016 | 16 | |
| 16 | 2015 | 15 | |
| 17 | 2021 | 12 | |
| 18 | 2009 | 12 | |
| 19 | 2017 | 10 | |
| 20 | Doxorubicin overcomes resistance to drozitumab by antagonizing Inhibitor of Apoptosis Proteins (IAPs). | 2014 | 8 |
About Mark DeNichilo
Mark DeNichilo is a scholar working on Molecular Biology, Immunology, Immunology and Allergy, Cancer Research and Oncology, having authored 25 papers that have together received 1.2k indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers), Angiogenesis and VEGF in Cancer (4 papers), Cell Adhesion Molecules Research (4 papers), Connective Tissue Growth Factor Research (4 papers), Immune cells in cancer (3 papers), Bone Metabolism and Diseases (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Muscle metabolism and nutrition (2 papers). The work is most often cited by research in Nephrology (179 citations), Clinical Biochemistry (74 citations), Rehabilitation (62 citations), Molecular Biology (651 citations) and Pathology and Forensic Medicine (133 citations). Mark DeNichilo has collaborated with scholars based in Australia, United States and Germany. Frequent co-authors include Pedro Cortés, Jerry Yee, Bruce L. Riser, Robert G. Narins, Shinong Wang, Raimund Hirschberg, Carrie E. Brubaker, Andreas Evdokiou, Vasilios Panagopoulos and Irene Zinonos. Their work appears in journals such as Cancer Medicine, Kidney International, Molecular Oncology, International Journal of Oncology and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.